Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


BLOOD FIBRINOGEN DECREASED side effect

What is BLOOD FIBRINOGEN DECREASED ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   BLOOD FIBRINOGEN DECREASED and Recently Reported Side Effects   BLOOD FIBRINOGEN DECREASED and 15 most Active Side Effect polls   BLOOD FIBRINOGEN DECREASED and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with BLOOD FIBRINOGEN DECREASED

ALBUMINAR  ALTEPLASE  CAPECITABINE  CLAMOXYL  DAUNORUBICIN  DEPAKOTE  LAMICTAL  LEFLUNOMIDE  MYLOTARG  NUVARING  ONCOVIN  PAXIL  PREVISCAN  PROGRAF  PROTAMINE  TASMAR  TEGRETOL  VFEND  


Leflunomide Side Effects Report #5676746-4
Physician from FRANCE reported LEFLUNOMIDE problem on Mar 03, 2008. Female patient, 34 years of age, was diagnosed with juvenile arthritis, therapeutic procedure and was treated with LEFLUNOMIDE. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen decreased, hepatic fibrosis, hepatic necrosis, hepatitis fulminant, hepatomegaly, hepatotoxicity, prothrombin level abnormal, serum ferritin increased, vitamin k deficiency, . LEFLUNOMIDE dosage: 20 MG/DAY. During the same period patient was treated with CHOLESTYRAMINE, ACETAMINOPHEN W, PREDNISONE, NICARDECREASEINE, CANDESARTAN CILEXETIL, CALCIUM CARBONATE, CHOLECALCIFEROL. Patient was hospitalized. Patient recovered.

Albuminar Side Effects Report #5695380-3
ALBUMINAR problem was reported by a Pharmacist from UNITED STATES on Mar 13, 2008. Female patient, 65 years of age, weighting 238.3 lb, was diagnosed with myasthenia gravis, plasmapheresis and was treated with ALBUMINAR. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen decreased, blood glucose increased, catheter site haemorrhage, haemolysis, international normalised ratio increased, platelet count decreased, prothrombin time prolonged, rectal haemorrhage, upper gastrointestinal haemorrhage, . ALBUMINAR dosage: unknown. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5475404-9
Physician from JAPAN reported MYLOTARG problem on Sept 26, 2007. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen decreased, condition aggravated, disseminated intravascular coagulation, fibrin degradation products increased, hypokalaemia, platelet count decreased, white blood cell count decreased, . MYLOTARG dosage: unknown. During the same period patient was treated with RENIVACE, ADALAT, METHYCOBAL, POTASSIUM CHLORIDE, MUCOSOLVAN, LEVOFLOXACIN, DIFLUCAN. Patient recovered.

Oncovin Side Effects Report #5417778-0
ONCOVIN problem was reported by a Consumer or non-health professional from JAPAN on Aug 10, 2007. Female patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with ONCOVIN. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen decreased, hyponatraemia, pancytopenia, . ONCOVIN dosage: unknown. During the same period patient was treated with GLEEVEC. Patient was hospitalized. Patient recovered.


Alteplase Side Effects Report #5750565-2
Pharmacist from UNITED STATES reported ALTEPLASE problem on May 23, 2008. Female patient, 69 years of age, was diagnosed with arterial thrombosis and was treated with ALTEPLASE. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen decreased, haematuria, . ALTEPLASE dosage: 8.3 MG IN 1000 ML NS INFUSION IV. During the same period patient was treated with HYDROMORPHONE, MORPHINE, CEFAZOLIN, HEPARIN. Patient recovered.

Clamoxyl Side Effects Report #5313860-7
CLAMOXYL problem was reported by a Consumer or non-health professional from FRANCE on Apr 27, 2007. Female patient, child 3 years of age, weighting 26.46 lb, was treated with CLAMOXYL. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen decreased, international normalised ratio abnormal, prothrombin level abnormal, . CLAMOXYL dosage: unknown. During the same period patient was treated with PREVISCAN, FERROSTRANE, PARACETAMOL, LACTEOL, TIORFAN, FLAGYL, CODENFAN, FOLDINE. Patient was hospitalized. Patient recovered.

Previscan Side Effects Report #5333701-1
Consumer or non-health professional from FRANCE reported PREVISCAN problem on May 07, 2007. Female patient, child 3 years of age, weighting 26.46 lb, was treated with PREVISCAN. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen decreased, international normalised ratio abnormal, prothrombin level abnormal, . PREVISCAN dosage: 2MG PER DAY. During the same period patient was treated with CLAMOXYL, FERROSTRANE, PARACETAMOL, TIORFAN, FLAGYL, CODENFAN, FOLDINE, LACTEOL. Patient was hospitalized. Patient recovered.

Nuvaring Side Effects Report #5300368-8
NUVARING problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2007. Female patient, 35 years of age, weighting 210.0 lb, was diagnosed with polycystic ovaries and was treated with NUVARING. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen decreased, contusion, deep vein thrombosis, weight increased, . NUVARING dosage: unknown. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #5306661-7
Physician from JAPAN reported VFEND problem on Apr 13, 2007. Male patient, 33 years of age, was diagnosed with infection prophylaxis, acute lymphocytic leukaemia and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen decreased, . VFEND dosage: DAILY DOSE:300MG. During the same period patient was treated with ENDOXAN, ZOVIRAX, BAKTAR, LEVOFLOXACIN, GASTER, MUCOSTA. Patient recovered.


Prograf Side Effects Report #5542842-5
PROGRAF problem was reported by a Physician from UNITED STATES on Nov 27, 2007. Male patient, 17 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: biopsy kidney abnormal, blood fibrinogen decreased, blood lactate dehydrogenase increased, complement factor c3 decreased, fibrin d dimer increased, haemoglobin decreased, hydronephrosis, hypertension, . PROGRAF dosage: 4 MG,BID. During the same period patient was treated with MYCOPHENOLATE MOFETIL, CYTOMEGALOVIRUS IMMUNE GLOBIN, VALGANCICLOVIR, FLUCONAZOLE, TRIMETHOPRIM COMP. Patient recovered.

Protamine Side Effects Report #5492024-0
Pharmacist from UNITED STATES reported PROTAMINE SULPHATE problem on Oct 18, 2007. Female patient, 84 years of age, was diagnosed with coagulopathy and was treated with PROTAMINE SULPHATE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood fibrinogen decreased, platelet count decreased, pulmonary arterial pressure increased, right ventricular dysfunction, . PROTAMINE SULPHATE dosage: 350MG. Patient recovered.

Paxil Side Effects Report #5464283-1
PAXIL problem was reported by a Physician from JAPAN on Sept 10, 2007. Male patient, 74 years of age, was diagnosed with depression, insomnia and was treated with PAXIL. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time, blood fibrinogen decreased, disseminated intravascular coagulation, gastric ulcer, haemoglobin decreased, ileus, platelet count decreased, upper gastrointestinal haemorrhage, . PAXIL dosage: 10MG PER DAY. During the same period patient was treated with LORAZEPAM. Patient was hospitalized. Patient recovered.

Lamictal Side Effects Report #5403990-3
Consumer or non-health professional from FRANCE reported LAMICTAL problem on July 25, 2007. Female patient, 93 years of age, was diagnosed with convulsion and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood fibrinogen decreased, blood urea increased, disseminated intravascular coagulation, fibrin d dimer increased, haematoma, lung infection, lymphoma, . LAMICTAL dosage: 25MG THREE TIMES PER DAY. During the same period patient was treated with LEVOTHYROXINE, SERESTA, INIPOMP, MINOCIN, KARDEGIC. Patient was hospitalized. Patient died on 07/14/2007.

Tegretol Side Effects Report #5742240-5
TEGRETOL problem was reported by a Physician from JAPAN on May 12, 2008. Female patient, 32 years of age, was diagnosed with bipolar i disorder and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood fibrinogen decreased, contusion, gamma-glutamyltransferase increased, prothrombin level increased, prothrombin time prolonged, . TEGRETOL dosage: 800 MG/DAY. Patient recovered.


Capecitabine Side Effects Report #5691641-2
Health Professional from UNITED STATES reported CAPECITABINE problem on Oct 24, 2005. Female patient, 57 years of age, weighting 185.0 lb, was diagnosed with breast cancer, neutropenia and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: acidosis, blood fibrinogen decreased, blood pressure decreased, body temperature decreased, chest discomfort, coagulopathy, disease progression, disseminated intravascular coagulation, dyspnoea, . CAPECITABINE dosage: unknown. During the same period patient was treated with HERCEPTIN, CORTISOL, GEMZAR, NEUPOGEN, DEXTROSE, ADVAIR HFA, ALBUTEROL, ATROVENT. Patient was hospitalized. Patient died on 10/01/2005.

Clamoxyl Side Effects Report #5696087-9
CLAMOXYL problem was reported by a Consumer or non-health professional from FRANCE on Apr 02, 2008. Male patient, 30 years of age, was diagnosed with rhinitis and was treated with CLAMOXYL. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, blood fibrinogen decreased, coagulopathy, convulsion, disseminated intravascular coagulation, infection, rash, thrombocytopenia, . CLAMOXYL dosage: unknown. Patient was hospitalized. Patient recovered.

Tegretol Side Effects Report #5710934-3
Physician from JAPAN reported TEGRETOL problem on Apr 09, 2008. Female patient, 32 years of age, was diagnosed with bipolar i disorder and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood fibrinogen decreased, gamma-glutamyltransferase increased, prothrombin level increased, prothrombin time prolonged, . TEGRETOL dosage: 800 MG/DAY. Patient recovered.

Prograf Side Effects Report #5282387-3
PROGRAF problem was reported by a Physician from JAPAN on Mar 09, 2007. Female patient, 63 years of age, weighting 74.96 lb, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: anxiety disorder, blood fibrinogen decreased, cytomegalovirus viraemia, gastroenteritis, graft versus host disease, hypocoagulable state, . PROGRAF dosage: 0.8 MG, UID/QD, IV DRIP. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.

Tasmar Side Effects Report #5670097-X
Physician from CANADA reported TASMAR problem on Feb 29, 2008. Female patient, 74 years of age, was diagnosed with parkinson's disease and was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, biliary cirrhosis, blood fibrinogen decreased, blood glucose increased, blood iron increased, depressed level of consciousness, diarrhoea, dilatation atrial, gallbladder disorder, . TASMAR dosage: 100 MG; TID; PO; 50 MG; TID; PO. During the same period patient was treated with IBUPROFEN, TYLENOL NO, ARTANE, PROVERA, PERMAX, PREMARIN, ASPIRIN. Patient died.


Tasmar Side Effects Report #5449584-5
TASMAR problem was reported by a Physician from CANADA on May 11, 2006. Female patient, 74 years of age, was treated with TASMAR. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, biliary cirrhosis, blood fibrinogen decreased, blood glucose increased, blood iron increased, blood lactate dehydrogenase increased, blood urea increased, depressed level of consciousness, diarrhoea, . TASMAR dosage: 300 MG; QD; PO. During the same period patient was treated with IBUPROFEN, TYLENOL NO, ARTANE, PROVERA, PERMAX, PREMARIN, ASPIRIN, SINEMET. Patient died.

Depakote Side Effects Report #5707703-7
Health Professional from UNITED STATES reported DEPAKOTE problem on Apr 08, 2008. Male patient, 30 years of age, was diagnosed with mania and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, blood creatine phosphokinase increased, blood fibrinogen decreased, hepatic enzyme increased, liver injury, neutropenia, pyrexia, thrombocytopenia, . DEPAKOTE dosage: unknown. During the same period patient was treated with RISPERIDONE, TROPATEPINE HYDROCHLORIDE, CLONAZEPAM. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #5266033-0
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2007. Female patient, weighting 66.14 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: agitation, anaemia, blood fibrinogen decreased, blood urea increased, clostridium difficile toxin test positive, dehydration, gastrointestinal necrosis, haemodynamic instability, hepatic necrosis, . DAUNORUBICIN dosage: 53 MG. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about BLOOD FIBRINOGEN DECREASED side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about BLOOD FIBRINOGEN DECREASED